UB-165 is a drug which acts as an agonist at neuronal nicotinic acetylcholine receptors being a full agonist of the α3β2 isoform and a partial agonist of the α4β2* isoform. It is used to study the role of this receptor subtype in the release of dopamine and noradrenaline in the brain,[1][2] and has also been used as a lead compound to derive a number of other selective nicotinic receptor ligands.[3][4][5][6]
Identifiers | |
---|---|
| |
CAS Number |
|
PubChem CID |
|
Chemical and physical data | |
Formula | C13H15ClN2 |
Molar mass | 234.724 g·mol−1 |
3D model (JSmol) |
|
| |
(verify) |